6-Bromo-5-methoxy-2-methyl-2H-indazole, 97%, 250mg

4-chloro-1-methyl-1H-imidazole, 95.0%, 1g

N-(4-Hydroxyphenyl)propionamide, 95.0%, 5g

TERT-BUTYL (3R,4S)-3-(AMINOMETHYL)-4-HYDROXYPYRROLIDINE-1-CARBOXYLATE, 95.0%, 250mg

(S)-2-(1,4-Dibenzylpiperazin-2-yl)acetonitrile, 97%, 100mg

1-Acetyl-4-amino-piperidine, 97.0%, 5g

1-[4-(Dimethylamino)phenyl]ethanone, 97.0%, 1g

2'-Phenyl-2,2,2-trifluoroacetophenone, 97.0%, 2g

Gal alpha(1-3) N-Glycan 2AB (500pmol/vial)>95.0%(HPLC)1vial

2,3-DIBROMO-4-FLUOROBENZONITRILE, 95.0%, 250mg

GC capillary column ROTI®Cap-5, 50 m, 0.32 mm, 1.00 µm, 1 Piece(s)

2-Chloro-4-ethoxy-1-nitrobenzene, 98%, 1g

4-(1-Piperazinyl)-1H-indole, 95.0%, 1g